| James A Warshaw, MD, PHD | |
|
2005 Bay St, Suite 204b, Taunton, MA 02780-1085 | |
| (508) 821-9400 | |
| (508) 821-9151 |
| Full Name | James A Warshaw |
|---|---|
| Gender | Male |
| Speciality | Endocrinology |
| Experience | 32 Years |
| Location | 2005 Bay St, Taunton, Massachusetts |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356306211 | NPI | - | NPPES |
| 3160378 | Medicaid | MA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 79137 (Massachusetts) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Premier Healthcare Inc | 1254233158 | 52 |
| Parcare Community Health Network Inc | 4981823390 | 71 |
News Archive
Researchers at the National Institutes of Health in Bethesda, Maryland, have shown how certain synthetic nanobodies bind to the agent that causes coronavirus disease 2019 (COVID-19) – a development that could help inform the design of therapies.
In a recent bioRxiv* preprint research paper, M. Gordon Joyce et al. designed engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of prefusion Spike (S), S1 and receptor-binding domain (RBD). They demonstrated that these immunogens induced robust S-binding, ACE2 (angiotensin-converting enzyme)-inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2 in mice.
Boston Catholics have asked Pope Benedict to intervene in the sale of Caritas Christi Health Care, a nonprofit Catholic hospital, to Cerberus Capital Management, a private equity firm, despite pledges that the hospital will retain its "religious identity," The Boston Globe reports.
The centers are designed to avoid expensive and often time-consuming patient transfers. Meanwhile, telemedicine bolsters intensive care services in rural Maryland, and a hospital system in Camden, N.J. overhauls the way it cares for the poorest and sickest patients
› Verified 3 days ago
| Entity Name | Albany Medical College |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1629008537 PECOS PAC ID: 1759293111 Enrollment ID: O20031125000386 |
News Archive
Researchers at the National Institutes of Health in Bethesda, Maryland, have shown how certain synthetic nanobodies bind to the agent that causes coronavirus disease 2019 (COVID-19) – a development that could help inform the design of therapies.
In a recent bioRxiv* preprint research paper, M. Gordon Joyce et al. designed engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of prefusion Spike (S), S1 and receptor-binding domain (RBD). They demonstrated that these immunogens induced robust S-binding, ACE2 (angiotensin-converting enzyme)-inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2 in mice.
Boston Catholics have asked Pope Benedict to intervene in the sale of Caritas Christi Health Care, a nonprofit Catholic hospital, to Cerberus Capital Management, a private equity firm, despite pledges that the hospital will retain its "religious identity," The Boston Globe reports.
The centers are designed to avoid expensive and often time-consuming patient transfers. Meanwhile, telemedicine bolsters intensive care services in rural Maryland, and a hospital system in Camden, N.J. overhauls the way it cares for the poorest and sickest patients
› Verified 3 days ago
| Entity Name | Premier Healthcare Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760436190 PECOS PAC ID: 1254233158 Enrollment ID: O20040122000144 |
News Archive
Researchers at the National Institutes of Health in Bethesda, Maryland, have shown how certain synthetic nanobodies bind to the agent that causes coronavirus disease 2019 (COVID-19) – a development that could help inform the design of therapies.
In a recent bioRxiv* preprint research paper, M. Gordon Joyce et al. designed engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of prefusion Spike (S), S1 and receptor-binding domain (RBD). They demonstrated that these immunogens induced robust S-binding, ACE2 (angiotensin-converting enzyme)-inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2 in mice.
Boston Catholics have asked Pope Benedict to intervene in the sale of Caritas Christi Health Care, a nonprofit Catholic hospital, to Cerberus Capital Management, a private equity firm, despite pledges that the hospital will retain its "religious identity," The Boston Globe reports.
The centers are designed to avoid expensive and often time-consuming patient transfers. Meanwhile, telemedicine bolsters intensive care services in rural Maryland, and a hospital system in Camden, N.J. overhauls the way it cares for the poorest and sickest patients
› Verified 3 days ago
| Entity Name | Weill Medical College Of Cornell |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417071945 PECOS PAC ID: 6800709023 Enrollment ID: O20040715000969 |
News Archive
Researchers at the National Institutes of Health in Bethesda, Maryland, have shown how certain synthetic nanobodies bind to the agent that causes coronavirus disease 2019 (COVID-19) – a development that could help inform the design of therapies.
In a recent bioRxiv* preprint research paper, M. Gordon Joyce et al. designed engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of prefusion Spike (S), S1 and receptor-binding domain (RBD). They demonstrated that these immunogens induced robust S-binding, ACE2 (angiotensin-converting enzyme)-inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2 in mice.
Boston Catholics have asked Pope Benedict to intervene in the sale of Caritas Christi Health Care, a nonprofit Catholic hospital, to Cerberus Capital Management, a private equity firm, despite pledges that the hospital will retain its "religious identity," The Boston Globe reports.
The centers are designed to avoid expensive and often time-consuming patient transfers. Meanwhile, telemedicine bolsters intensive care services in rural Maryland, and a hospital system in Camden, N.J. overhauls the way it cares for the poorest and sickest patients
› Verified 3 days ago
| Entity Name | Parcare Community Health Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730454083 PECOS PAC ID: 4981823390 Enrollment ID: O20140917002207 |
News Archive
Researchers at the National Institutes of Health in Bethesda, Maryland, have shown how certain synthetic nanobodies bind to the agent that causes coronavirus disease 2019 (COVID-19) – a development that could help inform the design of therapies.
In a recent bioRxiv* preprint research paper, M. Gordon Joyce et al. designed engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of prefusion Spike (S), S1 and receptor-binding domain (RBD). They demonstrated that these immunogens induced robust S-binding, ACE2 (angiotensin-converting enzyme)-inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2 in mice.
Boston Catholics have asked Pope Benedict to intervene in the sale of Caritas Christi Health Care, a nonprofit Catholic hospital, to Cerberus Capital Management, a private equity firm, despite pledges that the hospital will retain its "religious identity," The Boston Globe reports.
The centers are designed to avoid expensive and often time-consuming patient transfers. Meanwhile, telemedicine bolsters intensive care services in rural Maryland, and a hospital system in Camden, N.J. overhauls the way it cares for the poorest and sickest patients
› Verified 3 days ago
| Entity Name | Ajay 28 Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609342898 PECOS PAC ID: 9830436328 Enrollment ID: O20190122002046 |
News Archive
Researchers at the National Institutes of Health in Bethesda, Maryland, have shown how certain synthetic nanobodies bind to the agent that causes coronavirus disease 2019 (COVID-19) – a development that could help inform the design of therapies.
In a recent bioRxiv* preprint research paper, M. Gordon Joyce et al. designed engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of prefusion Spike (S), S1 and receptor-binding domain (RBD). They demonstrated that these immunogens induced robust S-binding, ACE2 (angiotensin-converting enzyme)-inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2 in mice.
Boston Catholics have asked Pope Benedict to intervene in the sale of Caritas Christi Health Care, a nonprofit Catholic hospital, to Cerberus Capital Management, a private equity firm, despite pledges that the hospital will retain its "religious identity," The Boston Globe reports.
The centers are designed to avoid expensive and often time-consuming patient transfers. Meanwhile, telemedicine bolsters intensive care services in rural Maryland, and a hospital system in Camden, N.J. overhauls the way it cares for the poorest and sickest patients
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James A Warshaw, MD, PHD 2005 Bay St, Suite 204b, Taunton, MA 02780-1085 Ph: (508) 821-9400 | James A Warshaw, MD, PHD 2005 Bay St, Suite 204b, Taunton, MA 02780-1085 Ph: (508) 821-9400 |
News Archive
Researchers at the National Institutes of Health in Bethesda, Maryland, have shown how certain synthetic nanobodies bind to the agent that causes coronavirus disease 2019 (COVID-19) – a development that could help inform the design of therapies.
In a recent bioRxiv* preprint research paper, M. Gordon Joyce et al. designed engineered nanoparticle immunogens that recapitulate the structural and antigenic properties of prefusion Spike (S), S1 and receptor-binding domain (RBD). They demonstrated that these immunogens induced robust S-binding, ACE2 (angiotensin-converting enzyme)-inhibition, and authentic and pseudovirus neutralizing antibodies against SARS-CoV-2 in mice.
Boston Catholics have asked Pope Benedict to intervene in the sale of Caritas Christi Health Care, a nonprofit Catholic hospital, to Cerberus Capital Management, a private equity firm, despite pledges that the hospital will retain its "religious identity," The Boston Globe reports.
The centers are designed to avoid expensive and often time-consuming patient transfers. Meanwhile, telemedicine bolsters intensive care services in rural Maryland, and a hospital system in Camden, N.J. overhauls the way it cares for the poorest and sickest patients
› Verified 3 days ago
Priti A Patel, MD Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 233 Winthrop Street, Taunton, MA 02780 Phone: 508-880-0070 Fax: 508-880-2989 | |
Robert J Mcnamee, M.D. Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 72 Washington St, Suite 1300, Taunton, MA 02780 Phone: 508-824-5865 Fax: 508-823-9108 | |
Kabir Chuttani, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 72 Washington St, Suite 1400-1700, Taunton, MA 02780 Phone: 508-880-0077 Fax: 508-880-5247 | |
Yun Xia, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 100 Industrial Park Rd, Suite 1, Taunton, MA 02780 Phone: 508-822-2266 Fax: 508-823-5689 | |
Cristina Cellurale, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 91 Washington St Unit 301, Taunton, MA 02780 Phone: 508-824-5865 Fax: 508-823-9108 | |
Khalid A Zaalook, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: Morton Hospital & Medical Center, 88 Washington Street, Taunton, MA 02780 Phone: 508-828-7293 | |
Yelena Levin, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 152 Dean St, Taunton, MA 02780 Phone: 508-824-3872 Fax: 508-828-4925 |